Waning immunity and re-emergence of measles and mumps in the vaccine era

被引:29
|
作者
Yang, Luojun [1 ,2 ]
Grenfell, Bryan T. [1 ,3 ]
Mina, Michael J. [2 ,4 ,5 ]
机构
[1] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA
[2] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Dept Immunol & Infect Dis, Ctr Communicable Dis Dynam, Boston, MA 02115 USA
[3] NIH, Div Int Epidemiol & Populat Studies, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA
[4] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA
[5] Harvard Med Sch, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
LIVED PLASMA-CELLS; LONG-TERM; HUMORAL IMMUNITY; UNITED-STATES; SCHOOL POPULATION; LATE CONVALESCENT; VIRUS-ANTIBODIES; SERUM ANTIBODY; HERPES-ZOSTER; RISK-FACTORS;
D O I
10.1016/j.coviro.2020.05.009
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Vaccine-preventable diseases (VPD) including measles and mumps have been re-emerging in countries with sustained high vaccine coverage. For mumps, waning immunity has been recognized as a major contributor to recent outbreaks. Although unvaccinated individuals account for most cases in recent measles outbreaks, the role of immune waning remains unclear. Accumulating serological and epidemiological evidence suggests that natural immunity induced by infection may be more durable compared to vaccine-induced immunity. As the proportion of population immunity via vaccination gradually increases and boosting through natural exposures becomes rare, risk of outbreaks may increase. Mechanistic insights into the coupled immuno-epidemiological dynamics of waning and boosting will be important to understand optimal vaccination strategies to combat VPD re-emergence and achieve eradication.
引用
收藏
页码:48 / 54
页数:7
相关论文
共 50 条
  • [41] Re-emergence of neuroinfectiology
    Baumgaertner, Wolfgang
    Loescher, Wolfgang
    ACTA NEUROPATHOLOGICA, 2016, 131 (02) : 155 - 158
  • [42] A Third Dose of Measles-Mumps-Rubella Vaccine to Improve Immunity Against Mumps in Young Adults
    Kaaijk, Patricia
    Wijmenga-Monsuur, Alienke J.
    van Houten, Marlies A.
    Veldhuijzen, Irene K.
    ten Hulscher, Hinke, I
    Kerkhof, Jeroen
    van der Klis, Fiona R.
    van Binnendijk, Rob S.
    JOURNAL OF INFECTIOUS DISEASES, 2020, 221 (06): : 902 - 909
  • [43] Potential impacts of schedule changes, waning immunity and vaccine uptake on measles elimination in Australia
    Wood, James G.
    Gidding, Heather F.
    Heywood, Anita
    Macartney, Kristine
    McIntyre, Peter B.
    MacIntyre, C. Raina
    VACCINE, 2009, 27 (02) : 313 - 318
  • [44] Modelling antibody response to measles vaccine and subsequent waning of immunity in a low exposure population
    Mossong, J
    O'Callaghan, CJ
    Ratnam, S
    VACCINE, 2000, 19 (4-5) : 523 - 529
  • [45] Trusting in the future: The re-emergence of state trust funds in the shale era
    Rabe, Barry G.
    Hampton, Rachel L.
    ENERGY RESEARCH & SOCIAL SCIENCE, 2016, 20 : 117 - 127
  • [46] Evidence for Residual Immunity to Smallpox After Vaccination and Implications for Re-emergence
    Kunasekaran, Mohana Priya
    Chen, Xin
    Costantino, Valentina
    Chughtai, Abrar Ahmad
    MacIntyre, Chandini Raina
    MILITARY MEDICINE, 2019, 184 (11-12) : E668 - E679
  • [47] WANING HERD IMMUNITY: A CHALLENGE FOR ERADICATION OF MEASLES
    Moghadas, Seyed M.
    Alexander, Murray E.
    Sahai, Beni M.
    ROCKY MOUNTAIN JOURNAL OF MATHEMATICS, 2008, 38 (05) : 1587 - 1607
  • [48] MATERNALLY DERIVED IMMUNITY TO MEASLES AND MUMPS
    MURRAY, D
    VALDUSS, D
    DYKE, J
    CLINICAL RESEARCH, 1990, 38 (03): : A900 - A900
  • [49] Recurrent outbreaks of mumps in Lothian and the impact of waning immunity
    Waugh, C. J.
    Willocks, L. J.
    Templeton, Kate E.
    Stevenson, J.
    EPIDEMIOLOGY AND INFECTION, 2020, 148
  • [50] Do we need a new vaccine to control the re-emergence of pertussis?
    Mills, Kingston H.G.
    Ross, Padraig J.
    Allen, Aideen C.
    Wilk, Mieszko M.
    TRENDS IN MICROBIOLOGY, 2014, 22 (02) : 49 - 52